首页> 外文会议>Conference on Lasers and Electro-Optics Europe >Nanoscale plasmonics for molecular recognition and light-triggered molecular release
【24h】

Nanoscale plasmonics for molecular recognition and light-triggered molecular release

机译:用于分子识别和光触发的分子释放的纳米级血管分子

获取原文

摘要

Metallic nanostructures designed to provide plasmon resonances at specific optical frequencies and strong yet uniform near-field electromagnetic enhancements are useful nanodevices for light-driven sensing and actuation. The large local fields on the surface of these structures support surface-enhanced spectroscopies such as surface enhanced Raman spectroscopy (SERS). To use plasmonic nanostructures for molecular recognition, their properties must be exploited in combination with molecular layers that provide an optical signature that corresponds to capture of a target molecule. DNA oligomers bound to the surface of plasmonic nanostructures provide an optical signal that is sensitive to the conformational changes in the DNA itself due to interaction with other molecules, as would occur in binding events. This type of optical detection is label-free and reporter-free, that is, it does not depend upon the presence of a dye molecule bound to the DNA to provide an optical signal. DNA-drug interactions can be directly detected in this manner: the binding kinetics of chemotherapy drugs such as cisplatin can be directly monitored by this method, providing a streamlined spectroscopic approach to drug discovery.
机译:设计用于在特定光学频率和强且均匀的近场电磁增强处提供等离子体谐振的金属纳米结构是用于光电感测和致动的有用纳米型。这些结构表面上的大型局部场支持表面增强的光谱,例如表面增强的拉曼光谱(SERS)。为了使用阶段纳米结构进行分子识别,必须与提供与靶分分子的捕获的光学签名的分子层组合使用它们的性质。与等离子体纳米结构表面结合的DNA低聚物提供了由于与其他分子的相互作用而对DNA本身的构象变化敏感的光学信号,如结合事件所发生的那样。这种类型的光学检测是无标记的,没有报道,即,它不依赖于与DNA结合的染料分子的存在以提供光学信号。可以以这种方式直接检测到DNA-药物相互作用:通过该方法可以直接监测化疗药物如顺铂的结合动力学,提供了一种简化的药物发现的光谱方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号